TickrTrends ASND fair value analysis

Ascendis Pharma (ASND) Authorizes $400M Share Buyback

insidermonkey.com · 2026-09-21

On September 14, Ascendis Pharma A/S (NASDAQ:ASND) said its Board had authorized buying back up to $400 million of its own ordinary shares.

Read the full story at insidermonkey.com →

Is ASND undervalued? See TickrTrends' fair value analysis →